Omada Health, Inc.
OMDA
$18.73
$0.532.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Revenue | 49.47% | 48.92% | 56.61% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 49.47% | 48.92% | 56.61% | ||
| Cost of Revenue | 35.43% | 28.62% | 29.95% | ||
| Gross Profit | 57.80% | 62.30% | 83.88% | ||
| SG&A Expenses | 32.04% | 33.77% | 19.08% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 30.54% | 28.23% | 19.35% | ||
| Operating Income | 70.52% | 56.72% | 53.34% | ||
| Income Before Tax | 65.55% | 50.33% | 50.19% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 65.55% | 50.33% | 50.19% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 65.55% | 50.33% | 50.19% | ||
| EBIT | 70.52% | 56.72% | 53.34% | ||
| EBITDA | 84.18% | 66.25% | 58.13% | ||
| EPS Basic | 95.35% | 82.71% | 54.71% | ||
| Normalized Basic EPS | 98.43% | 82.70% | 54.71% | ||
| EPS Diluted | 95.35% | 82.71% | 54.71% | ||
| Normalized Diluted EPS | 98.43% | 82.70% | 54.71% | ||
| Average Basic Shares Outstanding | 640.34% | 187.24% | 9.98% | ||
| Average Diluted Shares Outstanding | 640.34% | 187.24% | 9.98% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||